Abstract
Hypoxia has been discussed as a possible factor of obstetric complications in the pathophysiology of schizophrenia. This study investigated the effects of chronic neonatal hypoxia in rats as an animal model of schizophrenia. Methods: (1) After chronic neonatal hypoxia between postnatal day (PD) 4 and 8, half of the pups were fostered by normally treated nurse animals to control for possible maternal effects and (2) tested on PD 36, 86, 120, and 150 using three different behavioral tests: prepulse inhibition (PPI), social interaction and recognition, and motor activity in an open field. (3) Before the PD 150 test, 50% of the animals had been chronically treated with the antipsychotic drug clozapine (45 mg/kg/day). (4) At PD 155, different brain regions have been used for expression profiling of synaptic genes on cDNA microarrays (“glutamate chip”) with qRT-PCR confirmation. Additionally, at PD 11 and 120, NMDA receptor binding and expression of NMDA receptor subunits have been performed. Rats exposed to hypoxia exhibited deficits in locomotor activity on PD 86, 120, and 150, as well as a PPI deficit on PD 120 and 150 in adulthood, but not before. Chronic treatment with clozapine reversed hypoxia-induced PPI deficits, but not the decreased locomotor activity. In a second experiment, where clozapine was chronically administered before PD 120, development of the PPI deficit in the animals exposed to hypoxia was prevented. In several brain regions, presynaptic genes such as SNAP-25, syntaxin 1A, neurexin, neuropeptide Y, and complexin I were downregulated and the NR1 subunit of the NMDA receptor was upregulated by hypoxia. These differential gene regulations could be partially compensated for by clozapine treatment. NMDA receptor binding was decreased at PD 11 and expression of the NR1 subunit was increased at PD 11 and 120. The time course of hypoxia-induced PPI deficits and their reversal by clozapine support the validity of our animal model and the hypothesis that hypoxia as a factor of obstetric complications plays a role in the pathophysiology of schizophrenia. Differential gene expression in cortical and subcortical brain regions as well as correlations to deficits of PPI support the view of an involvement of synapse-associated gene products and glutamatergic and GABAergic neurotransmission in the pathophysiology of behavioral deficits occurring as delayed responses to neonatal hypoxia in adulthood.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cannon, T.D., Rosso, I.M., Bearden, C.E., Sanchez, L.E., and Hadley, T. (1999) A prospective cohort study of neurodevelopmental processes in the genesis and epigenesis of schizophrenia. Dev Psychopathol 11, 467–485.
McNeil, T.F., Cantor-Graae, E., and Ismail, B. (2000a) Obstetric complications and congenital malformation in schizophrenia. Brain Res Brain Res Rev 31, 166–178.
Dalman, C., Thomas, H.V., David, A.S., Gentz, J., Lewis, G., and Allebeck, P. (2001) Signs of asphyxia at birth and risk of schizophrenia. Population-based case-control study. Br J Psychiatry 179, 403–408.
Cannon, T.D., van Erp, T.G., Rosso, I.M., Huttunen, M., Lönnqvist, J., Pirkola, T., Salonen, O., Valanne, L., Poutanen, V.P., and Standertskjöld-Nordenstam, C.G. (2002) Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry 59, 35–41.
McNeil, T.F., Cantor-Graae, E., and Weinberger, D.R. (2000b) Relationship of obstetric complications and differences in size of brain structures in monozygotic twin pairs discordant for schizophrenia. Am J Psychiatry 157, 203–212.
Van Erp, T.G., Saleh, P.A., Rosso, I.M., Huttunen, M., Lönnqvist, J., Pirkola, T., Salonen, O., Valanne, L., Poutanen, V.P., Standertskjöld-Nordenstam, C.G., and Cannon, T.D. (2002) Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am J Psychiatry 159, 1514–1520.
Verdoux, H., Geddes, J.R., Takei, N., Lawrie, S.M., Bovet, P., Eagles, J.M., Heun, R., McCreadie, R.G., McNeil, T.F., O’Callaghan, E., Stober, G., Willinger, M.U., Wright, P., and Murray, R.M. (1997) Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data. Am J Psychiatry 154, 1220–1227.
Weinberger, D.R. (1996) On the plausibility of “the neurodevelopmental hypothesis” of schizophrenia. Neuropsychopharmacology 14, 1S–11S.
Ikonomidou, C., Mosinger, J.L., Salles, K.S., Labruyere, J., and Olney, J.W. (1989) Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity. J Neurosci 9, 2809–2818.
Dobbing, J., and Sands, J. (1979) Comparative aspects of the brain growth spurt. Early Hum Dev 3, 79–83.
Tremblay, E., Roisin, M.P., Represa, A., Charriaut-Marlangue, C., and Ben-Ari, Y. (1988) Transient increased density of NMDA binding sites in the developing rat hippocampus. Brain Res 461, 393–396.
McDonald, J.W., and Johnston, M.V. (1990) Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Brain Res Rev 15, 41–70.
Johnston, M.V. (1995) Neurotransmitters and vulnerability of the developing brain. Brain Dev 17, 301–306.
Represa, A., Tremblay, E., and Ben-Ari, Y. (1989) Transient increase of NMDA-binding sites in human hippocampus during development. Neurosci Lett 99, 61–66.
Ritter, L.M., Unis, A.S., and Meador-Woodruff, J.H. (2001) Ontogeny of ionotropic glutamate receptor expression in human fetal brain. Brain Res Dev Brain Res 127, 123–133.
Ishii, T., Moriyoshi, K., Sugihara, H., Sakurada, K., Kadotani, H., Yokoi, M., Akazawa, C., Shigemoto, R., Mizuno, N., and Masu, M. (1993) Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem 268, 2836–2843.
Monyer, H., Burnashev, N., Laurie, D.J., Sakmann, B., and Seeburg, P.H. (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12, 529–540.
Mattson, M.P., Lee, R.E., Adams, M.E., Guthrie, P.B., and Kater, S.B. (1988) Interactions between entorhinal axons and target hippocampal neurons: a role for glutamate in the development of hippocampal circuitry. Neuron 1, 865–876.
McDonald, J.W., Silverstein, F.S., and Johnston, M.V. (1988) Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res 459, 200–203.
Brewer, G.J., and Cotman, C.W. (1989) NMDA receptor regulation of neuronal morphology in cultured hippocampal neurons. Neurosci Lett 99, 268–273.
Brooks, W.J., Petit, T.L., LeBoutillier, J.C., and Lo, R. (1991) Rapid alteration of synaptic number and postsynaptic thickening length by NMDA: an electron microscopic study in the occipital cortex of postnatal rats. Synapse 8, 41–48.
Komuro, H., and Rakic, P. (1993) Modulation of neuronal migration by NMDA receptors. Science 260, 95–97.
Olney, J.W., and Farber, N.B. (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52, 998–1007.
Harrison, P.J., and Owen, M.J. (2003) Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 361, 417–419.
Schmitt, A., Fendt, M, Zink, M., Ebert, U., Starke, M., Berthold, M., Herb, A., Petroianu, G., Falkai, P., and Henn, F. (2007). Altered NMDA receptor expression and behaviour following postnatal hypoxia: potential relevance to schizophrenia. J Neural Transm 114: 239–248.
McNeil, T.F. (1988) Obstetric factors and perinatal injuries. In Tsuang M.T., and Simpson, J.C. (eds.), Handbook of schizophrenia, vol 3: Nosology, epidemiology and genetics. New York, NY, Elsevier, 319–344.
Weinberger, D.R. (1995) Neurodevelopmental perspectives on schizophrenia. In Blood, F.E., and Kupfer, D.J. (eds.), Psychopharmacology: The fourth generation of progress. New York, NY, Raven Press Ltd., 1171–1183.
Goodman, R. (1988): Are complications of pregnancy and birth causes of schizophrenia? Dev Med Child Neurol 30, 391–395.
Cannon, T.E., and Mednick, S.A. (1991) Fetal neural development and adult schizophrenia: An elaboration of the paradigm. In Mednick, S.A., Cannon, T.D., Barr, C.E., and Lyon, M. (eds.), Fetal neural development and adult schizophrenia. Cambridge, Cambridge University Press, 227–237.
Braff, D.L. (1992) Reply to cognitive therapy and schizophrenia. Schizophr Bull 18, 37–38.
Swerdlow, N.R., Geyer, M.A., and Braff, D.L. (2001) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 156, 194–215.
Lipska, B.K., Aultman, J.M., Verma, A., Weinberger, D.R., and Moghaddam, B. (2002) Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology 27, 47–54.
Lipska, B.K., Al-Amin, H.A., and Weinberger, D.R. (1998) Excitotoxic lesions of the rat medial prefrontal cortex. Effects on abnormal behaviors associated with neonatal hippocampal damage. Neuropsychopharmacology 19, 451–464.
Sandager-Nielsen, K., Andersen, M.B., Sager, T.N., Werge, T., and Scheel-Kruger, J. (2004) Effects of postnatal anoxia on striatal dopamine metabolism and prepulse inhibition in rats. Pharmacol Biochem Behav 77, 767–774.
Hermans, R.H., and Longo, L.D. (1994) Altered catecholaminergic behavioral and hormonal responses in rats following early postnatal hypoxia. Physiol Behav 55, 469–475.
Fendt, M., Lex, A., Falkai, P., Henn, F.A., and Schmitt, A. (2008) Behavioural alterations in rats following neonatal hypoxia and effects of clozapine: implications for schizophrenia. Pharmacopsychiatry 41(4),138–145.
Van den Buuse, M., Garner, B., and Koch, M. (2003) Neurodevelopmental animal models of schizophrenia: effects on prepulse inhibition. Curr Mol Med 3, 459–471.
Lipska, B.K., Halim, N.D., Segal, P.N., and Weinberger, D.R. (2002) Effects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult rat. J Neurosci 22, 2835–2842.
Eastwood, S.L., and Harrison, P.J. (2000) Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol Psychiatry 5(4), 425–432.
Eastwood, S.L., and Harrison, P.J. (2001) Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res Bull 55(5), 569–578.
Eastwood, S.L., and Harrison, P.J. (2005) Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophr Res 73(2–3), 159–172.
Eastwood, S.L., Cairns, N.J., and Harrison, P.J. (2000) Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex. Br J Psychiatry 176, 236–242.
Honer, W.G., Falkai, P., Bayer, T.A., Xie, J., Hu, L., Li, H.Y., Arango, V., Mann, J.J., Dwork, A.J., and Trimble, W.S. (2002) Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cereb Cortex 12(4), 349–356.
Knable, M.B., Barci, B.M., Webster, M.J., Meador-Woodruff, J., Torrey, E.F., and Stanley Neuropathology Consortium (2004) Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 9(6), 609–620.
Kuromitsu, J., Yokoi, A., Kawai, T., Nagasu, T., Aizawa, T., Haga, S., and Ikeda, K. (2001) Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder. Brain Res Gene Expr Patterns 1(1), 17–21.
Sawada, K., Young, C.E., Barr, A.M., Longworth, K., Takahashi, S., Arango, V., Mann, J.J., Dwork, A.J., Falkai, P., Phillips, A.G., and Honer, W.G. (2002) Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness. Mol Psychiatry 7(5), 484–492.
Sawada, K., Barr, A.M., Nakamura, M., Arima, K., Young, C.E., Dwork, A.J., Falkai, P., Phillips, A.G., and Honer, W.G. (2005.) Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch Gen Psychiatry 62(3), 263–272.
Sokolov, B.P., Tcherepanov, A.A., Haroutunian, V., and Davis, K.L. (2000) Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients. Biol Psychiatry 48(3), 184–196.
Brose, N. (2008) Altered complexin expression in psychiatric and neurological disorders: cause or consequence? Mol Cells 25(1), 7–19.
Mellios, N., Huang, H.S., Baker, S.P., Galdzicka, M., Ginns, E., and Akbarian, S. (2009) Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry 65, 1006–1014.
Hashimoto, T., Arion, D., Unger, T., Maldonado-Avilés, J.G., Morris, H.M., Volk, D.W., Mirnics, K., and Lewis, D.A. (2008) Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 13(2), 147–161.
Rujescu, D., Ingason, A., Cichon, S., Pietiläinen, O.P., Barnes, M.R., Toulopoulou, T., Picchioni, M., Vassos, E., Ettinger, U., Bramon, E., Murray, R., Ruggeri, M., Tosato, S., Bonetto, C., Steinberg, S., Sigurdsson, E., Sigmundsson, T., Petursson, H., Gylfason, A., Olason, P.I., Hardarsson, G., Jonsdottir, G.A., Gustafsson, O., Fossdal, R., Giegling, I., Möller, H.J., Hartmann, A.M., Hoffmann, P., Crombie, C., Fraser, G., Walker, N., Lonnqvist, J., Suvisaari, J., Tuulio-Henriksson, A., Djurovic, S., Melle, I., Andreassen, O.A., Hansen, T., Werge, T., Kiemeney, L.A., Franke, B., Veltman, J., Buizer-Voskamp, J.E., GROUP Investigators, Sabatti, C., Ophoff, R.A., Rietschel, M., Nöthen, M.M., Stefansson, K., Peltonen, L., St Clair, D., Stefansson, H., and Collier, D.A. (2009) Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 18(5), 988–996.
Fei, G., Guo, C., Sun, H.S., and Feng, Z.P. (2007) Chronic hypoxia stress-induced differential modulation of heat-shock protein 70 and presynaptic proteins. J Neurochem 100(1), 50–61.
Eastwood, S.L., Burnet, P.W., and Harrison, P.J. (2000) Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain. Synapse 36(3), 167–177.
Huang, X.F., Deng, C., and Zavitsanou, K. (2006) Neuropeptide Y mRNA expression levels following chronic olanzapine, clozapine and haloperidol administration in rats. Neuropeptides 40(3), 213–219.
Sommer, U., Schmitt, A., Heck, M., Fendt, M., Zink, M., Petroianu, G., Nieselt, K., Symons, S., Lex, A., Herrera-Marschitz, M., Spanagel, R., Falkai, P., and Gebicke-Haerter, P. (2009) Differential expression of presynaptic genes in a rat model of postnatal hypoxia: Relevance to schizophrenia. Eur Arch Psych Clin Neurosci 260 (Suppl 2), S81–S89.
Schmitt, U., Dahmen, N., Fischer, V., Weigmann, H., Rao, M.L., Reuss, S., and Hiemke, C. (1999) Chronic oral haloperidol and clozapine in rats: A behavioral evaluation. Neuropsychobiology 39, 86–91.
Schmitt, A., Zink, M., Muller, B., May, B., Herb, A., Jatzko, A., Braus, D.F., and Henn, F.A. (2003a) Effects of long-term antipsychotic treatment on NMDA receptor binding and gene expression of subunits. Neurochem Res 28, 235–241.
Schmitt, A., Zink, M., Petroianu, G., May, B., Braus, D.F., and Henn, F.A. (2003b) Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain. Neurosci Lett 347, 81–84.
Zink, M., Schmitt, A., May, B., Muller, B., Braus, D.F., and Henn, F.A. (2004a) Differential effects of long-term treatment with clozapine or haloperidol on GABA transporter expression. Pharmacopsychiatry 37, 171–174.
Zink, M., Schmitt, A., May, B., Muller, B., Demirakca, T., Braus, D.F., and Henn, F.A. (2004b) Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression. Schizophr Res 66, 151–157.
Thor, D.H., and Holloway, W.R. (1982) Social memory of the male laboratory rat. J Comp Physiol Psychol 96, 1000–1006.
Paxinos, G., and Watson, C. (1986) The rat brain in stereotaxic coordinates, 2nd edition. San Diego, CA, Academic.
Zilles, K., and Schleicher, A. (1995) Correlative imaging of transmitter receptor distributions in human cortex. In Stumpf, W.E., and Solomon, H.F. (eds.), Autoradiography and correlative imaging. San Diego, CA, Academic, 277–307.
Zilles, K., Qu, M.S., Kohling, R., and Speckmann, E.J. (1999) Ionotropic glutamate and GABA receptors in human epileptic neocortical tissue: quantitative in vitro receptor autoradiography. Neuroscience 94, 1051–1061.
Diehl, F., Grahlmann, S., Beier, M., and Hoheisel, J.D. (2001) Manufacturing DNA microarrays of high spot homogeneity and reduced background signal. Nucleic Acids Res 29, E38.
Koschmieder, A., Ma, D., Hoheisel, J., and Frohme, M. (2005) Construction of Libraries of Random External Controls (LOREC) for application in microarray experiments. Heidelberg, DKFZ, Degree Dissertation.
Yang, Y.H., Dudoit, S., Luu, P., and Speed, T.P. (2001) Normalization for cDNA microarray data. In Bittner, M.L., Chen, Y., Dorsel, A.N., and Dougherty, E.R. (eds.), Microarrays: Optical technologies and informatics. Proc SPIE 4266, 141–152.
Schadt, E.E., Li, C., Ellis, B., and Wong, W.H. (2001) Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. J Cell Biochem Suppl 37, 120–125.
Breitling, R., Armengaud, P., Amtmann, A., and Herzyk, P. (2004) Rank Products: A simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573, 83–92.
Susser, E.S., and Lin, S.P. (1992) Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944–1945. Arch Gen Psychiatry 49, 983–988.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Schmitt, A. et al. (2011). The Hypoxic Rat Model for Obstetric Complications in Schizophrenia. In: O'Donnell, P. (eds) Animal Models of Schizophrenia and Related Disorders. Neuromethods, vol 59. Humana Press. https://doi.org/10.1007/978-1-61779-157-4_4
Download citation
DOI: https://doi.org/10.1007/978-1-61779-157-4_4
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-156-7
Online ISBN: 978-1-61779-157-4
eBook Packages: Springer Protocols